Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Epoetin Alfa for Anemia in Cancer Patients
NCT01374373Phase 4Completed
- Sponsor
- Biosidus
- Start
- Jun 2011
- Primary completion
- Nov 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alpha in anemia, sponsored by Biosidus. Started Jun 2011; status: completed.
02
Drugs
epoetin alpha
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01374373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374373.